Novartis (NVS)

[debunker1]

Entresto is nothing more than an attempt by Novartis to extend the patent life of Diovan (Valsartan). There is nothing to prove that Entresto is any better than the now generically available Valsartan.

There are other things to watch for with regards to Novartis integrity, such as making facilities managers from a failed pump and dump like ArQule into an "automation guru". There are so many highly qualified people in the industry to choose from for such roles yet they hired a "facilities manager", how embarrassing, these pharmaceutical companies don't even make an honest effort anymore.